422 results on '"Crosbie, Philip"'
Search Results
2. Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage
3. Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review
4. Lung cancer in never smokers (LCINS): development of a UK national research strategy
5. Second Primary Lung Cancer – An Emerging Issue in Lung Cancer Survivors
6. Impact of skip mediastinal lymph node metastasis on outcomes after resection for primary lung cancer
7. Validation of lung cancer polygenic risk scores in a high-risk case-control cohort
8. Defining the road map to a UK national lung cancer screening programme
9. Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging
10. 181 Targeted Lung Health Check screening outcomes from invited ‘aged-in’ populations
11. 165 Can Pathway Navigation increase lung cancer screening uptake? Protocol for a nested randomised controlled trial and process evaluation
12. Risk perception and disease knowledge in attendees of a community-based lung cancer screening programme
13. Comparative transcriptome profiling of virulent and avirulent isolates of Neoparamoeba perurans
14. Likely uptake of a future lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study
15. Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context
16. Acceptability of adding a non-contrast abdominal CT scan to screen for kidney cancer and other abdominal pathology within a community-based CT screening programme for lung cancer: A qualitative study.
17. Analysis of the baseline performance of five UK lung cancer screening programmes
18. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom
19. An evaluation of CT radiation doses within the Yorkshire Lung Screening Trial
20. The radiology quality assurance process in the Yorkshire Lung Screening Trial, and findings from the baseline round of low dose CT screening for lung cancer
21. Parasitic isopods Ceratothoa banksii (Leach, 1818) and Nerocila orbignyi (Guérin-Méneville, 1832) of farmed Atlantic salmon and their potential as vectors of Neoparamoeba perurans (Young et al. 2007) in Tasmania
22. Managing Legal Risks in an Uncertain Environment
23. An evaluation of CT radiation doses within the Yorkshire Lung Screening Trial.
24. Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.
25. Outcome after curative treatment of patients diagnosed with clinical stage I lung cancer in the Yorkshire Lung Screening Trial
26. Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation
27. Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial
28. Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD
29. 174 The prevalence and clinical outcomes of incidental thymic lesions detected through Lung Cancer Screening
30. Variations in Genomic Testing in Non-small Cell Lung Carcinoma: A Healthcare Professional Survey of Current Practices in the UK
31. Abstract 3319: Breath-based detection of lung cancer using exogenous volatile organic compound targeting β-glucuronidase in the tumor microenvironment
32. The impact of real-world lung cancer screening programmes on downstream diagnostic capacity
33. Well-differentiated lung neuroendocrine tumours: concordance between histological findings in pre-operative biopsies and post-operative pathology including ki67 proliferation index
34. The impact of reminder invitations on participation in community-based lung cancer screening
35. Optimising eligibility criteria for lung cancer screening
36. Well-differentiated lung neuroendocrine tumours: outcomes from 10 years of lung resections at a regional thoracic surgical centre 2012–2022
37. The effectiveness of offering ongoing and repeated provision of co-located, opt-out smoking cessation support as part of a lung cancer screening programme
38. Six-year outcomes of subsolid nodules detected in the Manchester Lung Health Check screening pilot
39. Integrating multiple biomarkers for early lung cancer detection in people undergoing CT screening: The iDx-Lung Study – initial correlates of demographics with analytical results
40. Correction: Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom
41. Body composition and lung cancer-associated cachexia in TRACERx
42. The evolution of non-small cell lung cancer metastases in TRACERx
43. The evolution of lung cancer and impact of subclonal selection in TRACERx
44. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx
45. Diagnosis and treatment outcomes from prebronchodilator spirometry performed alongside lung cancer screening in a Lung Health Check programme
46. Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging
47. Clinical trials in cancer screening, prevention and early diagnosis (SPED): A systematic mapping review
48. Oral vaccination of first-feeding Atlantic salmon, Salmo salar L., confers greater protection against yersiniosis than immersion vaccination
49. Immune response of Barramundi (Lates calcarifer) to Vibrio harveyi bacterin
50. Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.